In the first psychedelic study tested on neurodegenerative disease patients, researchers have discovered that psilocybin therapy elicits meaningful improvements in mood, cognition, and motor symptoms — without serious side effects or worsened symptoms. Psilocybin is a natural compound found in certain psychoactive mushrooms, which have increasingly shown promise in treating depression and anxiety.
